Role of phototherapy in the era of biologics

[1]  A. Armstrong,et al.  Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis. , 2020, JAMA dermatology.

[2]  S. Feldman,et al.  Home UV Phototherapy. , 2020, Dermatologic clinics.

[3]  W. Liao,et al.  Beyond the Booth: Excimer Laser for Cutaneous Conditions. , 2020, Dermatologic clinics.

[4]  K. Thompson,et al.  Distinguishing Myth from Fact: Photocarcinogenesis and Phototherapy. , 2020, Dermatologic clinics.

[5]  A. Armstrong,et al.  Patient-Reported Outcomes of Adalimumab, Phototherapy, and Placebo in the Vascular Inflammation in Psoriasis Trial: A Randomized Controlled Study. , 2019, Journal of the American Academy of Dermatology.

[6]  S. Feldman,et al.  Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis , 2019, Children.

[7]  B. Strober,et al.  Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with phototherapy. , 2019, Journal of the American Academy of Dermatology.

[8]  A. Lyons,et al.  Successful treatment of solar urticaria with UVA1 hardening in three patients , 2019, Photodermatology, photoimmunology & photomedicine.

[9]  B. Strober,et al.  Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. , 2019, Journal of the American Academy of Dermatology.

[10]  W. Gulliver,et al.  Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents , 2018, Journal of cutaneous medicine and surgery.

[11]  M. Lebwohl,et al.  Review of safety and efficacy of approved systemic psoriasis therapies , 2018, International journal of dermatology.

[12]  B. Strober,et al.  Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with phototherapy. , 2019 .

[13]  M. Lebwohl,et al.  Biologics and Psoriasis: The Beat Goes On. , 2019, Dermatologic clinics.

[14]  A. Mostaghimi,et al.  Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015 , 2018, Journal of the American Academy of Dermatology.

[15]  Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000-2015 , 2018, Journal of the American Academy of Dermatology.

[16]  S. Ibbotson,et al.  Narrowband ultraviolet B treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments , 2018, The British journal of dermatology.

[17]  F. Aubin,et al.  Phototherapy in France: quantitative data (2007–2016) from the National Health Insurance Register , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  A. Mostaghimi,et al.  Perceptions of U.S. dermatology residency program directors regarding the adequacy of phototherapy training during residency , 2017, Photodermatology, photoimmunology & photomedicine.

[19]  L. Hynan,et al.  A cross‐sectional, comparative study of home vs in‐office NB‐UVB phototherapy for vitiligo , 2017, Photodermatology, photoimmunology & photomedicine.

[20]  K. Lavoie,et al.  Changing Provider Behavior in the Context of Chronic Disease Management: Focus on Clinical Inertia. , 2017, Annual review of pharmacology and toxicology.

[21]  E. Prens,et al.  Phototherapy of Psoriasis, a Chronic Inflammatory Skin Disease. , 2017, Advances in experimental medicine and biology.

[22]  A. Kimball,et al.  Managing the dose escalation of biologics in an era of cost containment: the need for a rational strategy☆☆☆ , 2016, International journal of women's dermatology.

[23]  J. Koo,et al.  Combining biologic and phototherapy treatments for psoriasis: safety, efficacy, and patient acceptability , 2016, Psoriasis.

[24]  S. Feldman,et al.  Training for prescribing in‐office and home phototherapy , 2015, Photodermatology, photoimmunology & photomedicine.

[25]  J. Koo,et al.  A cross‐sectional survey study to evaluate phototherapy training in dermatology residency , 2015, Photodermatology, photoimmunology & photomedicine.

[26]  Alan Menter,et al.  Phototherapy in dermatology: A call for action. , 2015, Journal of the American Academy of Dermatology.

[27]  S. Feldman,et al.  A guide to prescribing home phototherapy for patients with psoriasis: the appropriate patient, the type of unit, the treatment regimen, and the potential obstacles. , 2015, Journal of the American Academy of Dermatology.

[28]  M. Chiu,et al.  UV-based therapy. , 2014, Dermatologic clinics.

[29]  H. Hönigsmann,et al.  Phototherapy, psoriasis, and the age of biologics , 2014, Photodermatology, photoimmunology & photomedicine.

[30]  I. Hamzavi,et al.  Systematic Review of UV-Based Therapy for Psoriasis , 2013, American Journal of Clinical Dermatology.

[31]  H. Hönigsmann,et al.  History of phototherapy in dermatology , 2012, Photochemical & Photobiological Sciences.

[32]  W. Weger,et al.  Treatment with 311‐nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab‐treated patients: a randomized intraindividual trial , 2012, The British journal of dermatology.

[33]  H. Jacobe,et al.  Phototherapy in the age of biologics. , 2011, Seminars in cutaneous medicine and surgery.

[34]  W. Weger,et al.  Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry , 2011, The British journal of dermatology.

[35]  W. Weger,et al.  311 nm ultraviolet B‐accelerated response of psoriatic lesions in adalimumab‐treated patients , 2011, Photodermatology, photoimmunology & photomedicine.

[36]  N. Benáková.  Phototherapy of psoriasis in the era of biologics: still in. , 2011, Acta dermatovenerologica Croatica : ADC.

[37]  T. Gambichler,et al.  Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks , 2011, The British journal of dermatology.

[38]  J. Weinberg.  Recent Trends in Systemic Psoriasis Treatment Costs , 2011 .

[39]  S. Wolverton,et al.  Recent trends in systemic psoriasis treatment costs. , 2010, Archives of dermatology.

[40]  A. Gottlieb,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. , 2010, Journal of the American Academy of Dermatology.

[41]  B. Thiers.  Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy , 2009 .

[42]  R. Dawe,et al.  Incidence of skin cancers in 3867 patients treated with narrow‐band ultraviolet B phototherapy , 2008, The British journal of dermatology.

[43]  Steven R Feldman,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. , 2008, Journal of the American Academy of Dermatology.

[44]  R. Roelandts.  History of Human Photobiology , 2007 .

[45]  R. Stern,et al.  Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. , 2003, Journal of the American Academy of Dermatology.

[46]  J. Sullivan,et al.  Survey of phototherapy practice by dermatologists in Australia , 2002, The Australasian journal of dermatology.

[47]  S. Feldman,et al.  Phototherapy utilization for psoriasis is declining in the United States. , 2002, Journal of the American Academy of Dermatology.

[48]  M. Lebwohl.  Acitretin in combination with UVB or PUVA. , 1999, Journal of the American Academy of Dermatology.

[49]  H. Hönigsmann,et al.  Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. , 1991, Journal of the American Academy of Dermatology.

[50]  J. Parrish,et al.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. , 1974, The New England journal of medicine.